Search research articles
Contact Us
Filters
Showing results (441-450 of 476) with videos related to
Page
of 48
Sort By:
Critical Care (London, England)
|
April 19, 2015
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study
Mahipal G Sinnollareddy, Jason A Roberts, Jeffrey Lipman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 17, 2014
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?
Jason A Roberts, Sanjoy K Paul, Murat Akova, et al.
International Journal of Antimicrobial Agents
|
April 23, 2026
Population pharmacokinetics of total and free ceftriaxone in critically ill and non-critically ill hospitalised adult patients
Eko Setiawan, Alvaro Gonzalez, Saskia A Wölky, et al.
Intensive Care Medicine
|
January 13, 2016
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
Mohd H Abdul-Aziz, Helmi Sulaiman, Mohd-Basri Mat-Nor, et al.
Antimicrobial Agents and Chemotherapy
|
November 15, 2021
Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131
Minh-Duy Phan, Kate M Peters, Laura Alvarez Fraga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 29, 2014
Reply to Rhodes et al
Jason A Roberts, Sanjoy K Paul, Murat Akova, et al.
Antimicrobial Agents and Chemotherapy
|
August 4, 2022
Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model
Kamrul Islam, Fekade B Sime, Steven C Wallis, et al.
Anaesthesia, Critical Care & Pain Medicine
|
April 26, 2022
Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)
Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
Thorax
|
July 10, 2009
BTS guidelines for home oxygen in children
I M Balfour-Lynn, D J Field, P Gringras, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
November 1, 2017
Incremental research approach to describing the pharmacokinetics of ciprofloxacin during extracorporeal membrane oxygenation
Fabrice Sinnah, Kiran Shekar, Mohd H Abdul-Aziz, et al.
Page
of 48
Search research articles
Search
Showing results (441-450 of 476) with videos related to
Sort By:
Page
of 48
Critical Care (London, England)
|
April 19, 2015
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study
Mahipal G Sinnollareddy, Jason A Roberts, Jeffrey Lipman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 17, 2014
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?
Jason A Roberts, Sanjoy K Paul, Murat Akova, et al.
International Journal of Antimicrobial Agents
|
April 23, 2026
Population pharmacokinetics of total and free ceftriaxone in critically ill and non-critically ill hospitalised adult patients
Eko Setiawan, Alvaro Gonzalez, Saskia A Wölky, et al.
Intensive Care Medicine
|
January 13, 2016
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
Mohd H Abdul-Aziz, Helmi Sulaiman, Mohd-Basri Mat-Nor, et al.
Antimicrobial Agents and Chemotherapy
|
November 15, 2021
Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131
Minh-Duy Phan, Kate M Peters, Laura Alvarez Fraga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 29, 2014
Reply to Rhodes et al
Jason A Roberts, Sanjoy K Paul, Murat Akova, et al.
Antimicrobial Agents and Chemotherapy
|
August 4, 2022
Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model
Kamrul Islam, Fekade B Sime, Steven C Wallis, et al.
Anaesthesia, Critical Care & Pain Medicine
|
April 26, 2022
Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)
Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
Thorax
|
July 10, 2009
BTS guidelines for home oxygen in children
I M Balfour-Lynn, D J Field, P Gringras, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
November 1, 2017
Incremental research approach to describing the pharmacokinetics of ciprofloxacin during extracorporeal membrane oxygenation
Fabrice Sinnah, Kiran Shekar, Mohd H Abdul-Aziz, et al.
Page
of 48